Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial).

Lambert M, Bock T, Schöttle D, Golks D, Meister K, Rietschel L, Bussopulos A, Frieling M, Schödlbauer M, Burlon M, Huber CG, Ohm G, Pakrasi M, Chirazi-Stark MS, Naber D, Schimmelmann BG.

J Clin Psychiatry. 2010 Oct;71(10):1313-23. doi: 10.4088/JCP.09m05113yel. Epub 2010 Mar 23.

PMID:
20361911
2.

Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial).

Karow A, Reimer J, König HH, Heider D, Bock T, Huber C, Schöttle D, Meister K, Rietschel L, Ohm G, Schulz H, Naber D, Schimmelmann BG, Lambert M.

J Clin Psychiatry. 2012 Mar;73(3):e402-8. doi: 10.4088/JCP.11m06875.

PMID:
22490266
3.

Intensive treatment models and coercion.

Ohlenschlaeger J, Thorup A, Petersen L, Jeppesen P, Køster A, Munkner R, Nordentoft M.

Nord J Psychiatry. 2007;61(5):369-78.

PMID:
17990199
4.

Deinstitutionalization revisited: a 5-year follow-up of a randomized clinical trial of hospital-based rehabilitation versus specialized assertive intervention (OPUS) versus standard treatment for patients with first-episode schizophrenia spectrum disorders.

Nordentoft M, Øhlenschlaeger J, Thorup A, Petersen L, Jeppesen P, Bertelsen M.

Psychol Med. 2010 Oct;40(10):1619-26. doi: 10.1017/S0033291709992182. Epub 2010 Jan 11.

PMID:
20059798
5.

Clinical predictors of acute response with quetiapine in psychotic mood disorders.

Zarate CA Jr, Rothschild A, Fletcher KE, Madrid A, Zapatel J.

J Clin Psychiatry. 2000 Mar;61(3):185-9.

PMID:
10817103
6.

Substance abuse and first-episode schizophrenia-spectrum disorders. The Danish OPUS trial.

Petersen L, Jeppesen P, Thorup A, Ohlenschlaeger J, Krarup G, Ostergård T, Jørgensen P, Nordentoft M.

Early Interv Psychiatry. 2007 Feb;1(1):88-96. doi: 10.1111/j.1751-7893.2007.00015.x.

PMID:
21352112
7.

[OPUS: a randomised multicenter trial of integrated versus standard treatment for patients with a first-episode psychosis--secondary publication].

Nordentoft M, Petersen L, Jeppesen P, Thorup AA, Abel MB, Ohlenschlaeger J, Christensen TØ, Krarup G, Jørgensen P.

Ugeskr Laeger. 2006 Jan 23;168(4):381-4. Danish.

PMID:
16436240
8.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

9.

Effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia spectrum and bipolar I disorders: the 24-month follow-up ACCESS II study.

Schöttle D, Schimmelmann BG, Karow A, Ruppelt F, Sauerbier AL, Bussopulos A, Frieling M, Golks D, Kerstan A, Nika E, Schödlbauer M, Daubmann A, Wegscheider K, Lange M, Ohm G, Lange B, Meigel-Schleiff C, Naber D, Wiedemann K, Bock T, Lambert M.

J Clin Psychiatry. 2014 Dec;75(12):1371-9. doi: 10.4088/JCP.13m08817.

10.

Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.

McConville BJ, Arvanitis LA, Thyrum PT, Yeh C, Wilkinson LA, Chaney RO, Foster KD, Sorter MT, Friedman LM, Brown KL, Heubi JE.

J Clin Psychiatry. 2000 Apr;61(4):252-60.

PMID:
10830145
11.

Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial.

Bertelsen M, Jeppesen P, Petersen L, Thorup A, Øhlenschlaeger J, le Quach P, Christensen TØ, Krarup G, Jørgensen P, Nordentoft M.

Arch Gen Psychiatry. 2008 Jul;65(7):762-71. doi: 10.1001/archpsyc.65.7.762.

PMID:
18606949
13.

A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness.

Petersen L, Jeppesen P, Thorup A, Abel MB, Øhlenschlaeger J, Christensen TØ, Krarup G, Jørgensen P, Nordentoft M.

BMJ. 2005 Sep 17;331(7517):602. Epub 2005 Sep 2. Erratum in: BMJ. 2005 Nov 5;331(7524):1065.

14.

A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.

Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP.

J Clin Psychiatry. 2004 May;65(5):696-701.

PMID:
15163258
15.

A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.

Chengappa KN, Goldstein JM, Greenwood M, John V, Levine J.

Clin Ther. 2003 Feb;25(2):530-41.

PMID:
12749512
16.

Patient adherence and efficacy of quetiapine treatment in schizophrenia: results of a multicentre, naturalistic 6-month follow-up study.

Alptekin K, Aydin H, Gucer KM, Dilbaz N, Goka E, Esendemir C, Oguz H, Arabul G, Aslaner F, Ayer A, Celiker AR, Cirit H, Pinar Z, Unal A.

Int Clin Psychopharmacol. 2010 Nov;25(6):342-8. doi: 10.1097/YIC.0b013e32833e2431.

PMID:
20924243
17.

The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings.

Velligan DI, Prihoda TJ, Sui D, Ritch JL, Maples N, Miller AL.

J Clin Psychiatry. 2003 May;64(5):524-31.

PMID:
12755654
19.

Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.

Potkin SG, Thyrum PT, Bera R, Carreon D, Alva G, Kalali AH, Yeh C.

Clin Ther. 2002 Nov;24(11):1809-23.

PMID:
12501876
20.

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.

Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG.

Arch Gen Psychiatry. 1997 Jun;54(6):549-57.

PMID:
9193196

Supplemental Content

Support Center